36786264|t|Polymorphism of tmprss2 (rs12329760) but not ace2 (rs4240157), tmprss11a (rs353163) and cd147 (rs8259) is associated with the severity of COVID-19 in the Ukrainian population.
36786264|a|BACKGROUND AND AIM: Angiotensin-converting enzyme 2 (ACE2), transmembrane serine 2 and serine 11A proteases (TMPRSS2, TMPRSS11A), and a cell surface cluster of differentiation 147 (CD147) might be a gene candidate that exerts the susceptibility to and mortality from coronavirus disease 19 (COVID-19). The aim of this study was to investigate the associations between ace2, tmprss2, tmprss11a, and cd147 polymorphic variants and the severity of COVID-19 in the Ukrainian population. METHODS: The study population consisted of the Ukrainian population with COVID-19: patients without oxygen therapy (n=62), with non-invasive (n=92) and invasive (n=35) oxygen therapy, as well as control subjects (n=92). Allelic polymorphisms of ace2 rs4240157, tmprss2 rs12329760, and tmprss11a rs353163 were determined by real-time PCR, and cd147 rs8259 polymorphism was detected by PCR with subsequent restrictase analysis. We compared investigated polymorphisms distribution with other populations by meta-analysis. RESULTS: Our study is the first to obtain data about the distribution of investigated gene polymorphisms in the Ukrainian population: tmprss2 rs12329760 - CC 60.9%, CT 35.9%, TT 3.2%; tmprss11a rs353163 - CC 46.7%, CT 40.2%, TT 13.1%; ace2 rs4240157 - CC 7.6%, C 18.5%, CT 22.8%, TT 19.6%, T 31.5%; cd147 rs8259 - TT 60.9%, AT 32.6%, AA 6.5%. This distribution was similar to the Northern, Western and Southern European populations. There was a statistically significant difference in the frequency of tmprss2 polymorphic genotypes CC 57.1%, CT 28.6%, and TT 14.3% (P<0.05) in COVID-19 patients with invasive oxygen therapy in comparison with non-invasive oxygen therapy. This tmprss2 mutation occurs in the scavenger receptor cysteine-rich (SRCR) domain and might be important for protein-protein interaction in a calcium-dependent manner. CONCLUSIONS: Our study indicated the presence of an association between the tmprss2 rs12329760 polymorphism and the severity of COVID-19 in the Ukrainian population.
36786264	16	23	tmprss2	Gene	7113
36786264	25	35	rs12329760	SNP	tmVar:rs12329760;VariantGroup:0;CorrespondingGene:7113;RS#:12329760;CorrespondingSpecies:9606
36786264	45	49	ace2	Gene	59272
36786264	51	60	rs4240157	SNP	tmVar:rs4240157;VariantGroup:2;CorrespondingGene:59272;RS#:4240157;CorrespondingSpecies:9606
36786264	63	72	tmprss11a	Gene	339967
36786264	74	82	rs353163	SNP	tmVar:rs353163;VariantGroup:3;CorrespondingGene:339967;RS#:353163;CorrespondingSpecies:9606
36786264	95	101	rs8259	SNP	tmVar:rs8259;VariantGroup:1;CorrespondingGene:682;RS#:8259;CorrespondingSpecies:9606
36786264	138	146	COVID-19	Disease	MESH:D000086382
36786264	196	227	Angiotensin-converting enzyme 2	Gene	59272
36786264	229	233	ACE2	Gene	59272
36786264	285	292	TMPRSS2	Gene	7113
36786264	294	303	TMPRSS11A	Gene	339967
36786264	443	465	coronavirus disease 19	Disease	MESH:D000086382
36786264	467	475	COVID-19	Disease	MESH:D000086382
36786264	544	548	ace2	Gene	59272
36786264	550	557	tmprss2	Gene	7113
36786264	559	568	tmprss11a	Gene	339967
36786264	621	629	COVID-19	Disease	MESH:D000086382
36786264	732	740	COVID-19	Disease	MESH:D000086382
36786264	742	750	patients	Species	9606
36786264	759	765	oxygen	Chemical	MESH:D010100
36786264	827	833	oxygen	Chemical	MESH:D010100
36786264	904	908	ace2	Gene	59272
36786264	909	918	rs4240157	SNP	tmVar:rs4240157;VariantGroup:2;CorrespondingGene:59272;RS#:4240157;CorrespondingSpecies:9606
36786264	920	927	tmprss2	Gene	7113
36786264	928	938	rs12329760	SNP	tmVar:rs12329760;VariantGroup:0;CorrespondingGene:7113;RS#:12329760;CorrespondingSpecies:9606
36786264	944	953	tmprss11a	Gene	339967
36786264	954	962	rs353163	SNP	tmVar:rs353163;VariantGroup:3;CorrespondingGene:339967;RS#:353163;CorrespondingSpecies:9606
36786264	1007	1013	rs8259	SNP	tmVar:rs8259;VariantGroup:1;CorrespondingGene:682;RS#:8259;CorrespondingSpecies:9606
36786264	1312	1319	tmprss2	Gene	7113
36786264	1320	1330	rs12329760	SNP	tmVar:rs12329760;VariantGroup:0;CorrespondingGene:7113;RS#:12329760;CorrespondingSpecies:9606
36786264	1362	1371	tmprss11a	Gene	339967
36786264	1372	1380	rs353163	SNP	tmVar:rs353163;VariantGroup:3;CorrespondingGene:339967;RS#:353163;CorrespondingSpecies:9606
36786264	1413	1417	ace2	Gene	59272
36786264	1418	1427	rs4240157	SNP	tmVar:rs4240157;VariantGroup:2;CorrespondingGene:59272;RS#:4240157;CorrespondingSpecies:9606
36786264	1483	1489	rs8259	SNP	tmVar:rs8259;VariantGroup:1;CorrespondingGene:682;RS#:8259;CorrespondingSpecies:9606
36786264	1680	1687	tmprss2	Gene	7113
36786264	1755	1763	COVID-19	Disease	MESH:D000086382
36786264	1764	1772	patients	Species	9606
36786264	1787	1793	oxygen	Chemical	MESH:D010100
36786264	1834	1840	oxygen	Chemical	MESH:D010100
36786264	1855	1862	tmprss2	Gene	7113
36786264	1993	2000	calcium	Chemical	MESH:D002118
36786264	2095	2102	tmprss2	Gene	7113
36786264	2103	2113	rs12329760	SNP	tmVar:rs12329760;VariantGroup:0;CorrespondingGene:7113;RS#:12329760;CorrespondingSpecies:9606
36786264	2147	2155	COVID-19	Disease	MESH:D000086382
36786264	Association	MESH:D000086382	RS#:8259;CorrespondingGene:682
36786264	Association	MESH:D000086382	RS#:12329760;CorrespondingGene:7113
36786264	Association	MESH:D000086382	RS#:4240157;CorrespondingGene:59272
36786264	Association	MESH:D002118	RS#:12329760;CorrespondingGene:7113
36786264	Association	MESH:D000086382	RS#:353163;CorrespondingGene:339967
36786264	Association	MESH:D000086382	7113
36786264	Association	MESH:D000086382	59272
36786264	Association	MESH:D000086382	339967
36786264	Negative_Correlation	MESH:D010100	MESH:D000086382
36786264	Association	MESH:D000086382	682
36786264	Association	MESH:D000086382	7113
36786264	Association	MESH:D000086382	59272
36786264	Association	MESH:D000086382	339967

